Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death

Blood

Volumn 114, Issue 5, 2009, Pages 1026-1028

  Yu, Yu ^a   Iclozan, Cristina ^a   Yamazaki, Tomohide ^b   Yang, Xuexian ^b   Anasetti, Claudio ^a,c   Dong, Chen ^b   Yu, Xue Zhong ^a,c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FLICE INHIBITORY PROTEIN; BCL2L1 PROTEIN, MOUSE; CFLAR PROTEIN, MOUSE; FAS LIGAND; FASL PROTEIN, MOUSE; INTERLEUKIN 17; OVALBUMIN; PROTEIN BCL X; SMALL INTERFERING RNA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CLASSIFICATION; COMPARATIVE STUDY; GERMFREE ANIMAL; HELPER CELL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; RADIATION CHIMERA; REPORTER GENE; SECRETION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELLS, CULTURED; FAS LIGAND PROTEIN; GENES, REPORTER; IMMUNE TOLERANCE; IMMUNIZATION; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; RADIATION CHIMERA; RNA, SMALL INTERFERING; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 70349229827     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-210153     Document Type: Article

References (21)

1. Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 1999;17:221-253. (Pubitemid 29241124)
2. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today. 1993;14:338-339. (Pubitemid 23198165)
3. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol. 2007;7: 532-542.
4. Roberts AI, Devadas S, Zhang X, et al. The role of activation-induced cell death in the differentiation of T-helper-cell subsets. Immunol Res. 2003; 28:285-293. (Pubitemid 38091065)
5. Pandiyan P, Gartner D, Soezeri O, Radbruch A, Schulze-Osthoff K, Brunner-Weinzierl MC. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activationinduced cell death by a mechanism requiring PI3 kinase function. J Exp Med. 2004;199:831-842. (Pubitemid 38375203)
6. Zhang X, Brunner T, Carter L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/ FasL-mediated apoptosis. J Exp Med. 1997;185: 1837-1849. (Pubitemid 27242205)
7. Devadas S, Das J, Liu C, et al. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity. 2006;25:237-247. (Pubitemid 44224145)
8. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132.
9. Park H, Li Z, Yang XO, et al.Adistinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-1141. (Pubitemid 41541791)
10. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity. 2008;28:445-453.
11. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454-467.
12. Steinman L. A rush to judgment on Th17. J Exp Med. 2008;205:1517-1522.
13. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29:44-56.
14. Kirchhoff S, Muller WW, Krueger A, Schmitz I, Krammer PH. TCR-mediated up-regulation of c- FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J Immunol. 2000;165:6293-6300.
15. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem. 2001; 276:20633-20640. (Pubitemid 37411151)
16. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190-195. (Pubitemid 27297457)
17. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608. (Pubitemid 23259741)
18. L through caspase interaction. Proc Natl Acad Sci U S A. 1998;95:554-559.
19. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
20. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem. 2001;276:26605-26613. (Pubitemid 37412883)
21. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362-373.